Amplify Weight Loss Drug & Treatment ETF Rating $23.36 +0.23 (+0.99%) As of 09/3/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.57Holdings in THNR have an aggregate rating of Moderate Buy based on 220 analyst ratings issued in the past year covering 12 companies (69.7% of the portfolio).THNR Aggregate Price Target$23.36High Prediction$23.36Average Prediction$23.36Low Prediction$23.36Holdings in THNR have an aggregate price target of $23.36 and a range of $23.36 to $23.36 covering 12 companies (69.7% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy6 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 12 THNR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.28%LLYEli Lilly and Company$736.27+0.1%5 of 5 stars2.67$950.17 29.1%24Trending NewsAnalyst Revision8.44%NVONovo Nordisk A/S$56.75+0.7%4.3583 of 5 stars2.13$81.00 42.7%16Trending News7.73%REGNRegeneron Pharmaceuticals$563.80-2.4%4.8488 of 5 stars2.81$817.67 45.0%27Positive News6.94%AMGNAmgen$283.85-1.1%4.6477 of 5 stars2.32$304.43 7.2%22Trending NewsAnalyst Forecast5.61%ABBVAbbVie$211.59-0.2%4.69 of 5 stars2.92$214.95 1.6%26Trending News5.51%AZNAstraZeneca$82.11+2.4%2.5833 of 5 stars2.80$86.00 4.7%5Positive News5.51%GILDGilead Sciences$112.99+0.2%4.9797 of 5 stars2.88$115.39 2.1%26Positive News5.38%MRKMerck & Co., Inc.$84.21-1.5%4.9964 of 5 stars2.35$107.44 27.6%20Trending News5.29%PFEPfizer$24.76-0.9%4.8441 of 5 stars2.39$28.12 13.6%18Trending News3.39%HIMSHims & Hers Health$44.50+7.2%3.3145 of 5 stars1.92$38.92 -12.6%13Positive NewsGap Up2.86%VKTXViking Therapeutics$26.83-2.4%4.2605 of 5 stars3.00$86.92 224.0%14Positive NewsAnalyst Revision1.74%CRNXCrinetics Pharmaceuticals$34.65+4.1%3.7944 of 5 stars2.78$68.86 98.7%9News CoveragePositive News This page (NYSEARCA:THNR) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
